Using genetics to improve asthma treatment predictions
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
This study is looking at how your genes can help doctors figure out the best asthma treatments for you, so if you have moderate to severe asthma, you might be able to get a more personalized plan that works better for your needs.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11088302 on NIH RePORTER |
What this research studies
This research investigates how genetic information can be used to better predict responses to asthma treatments. By analyzing various biological markers and patient characteristics, the study aims to identify which patients are likely to benefit from specific therapies. The approach includes advanced genomic techniques and systems biology to create a more personalized treatment plan for individuals with moderate to severe asthma. Patients participating in this research may undergo assessments that help clarify their asthma type and treatment response.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with moderate to severe asthma, particularly those who have not responded well to existing treatments.
Not a fit: Patients with mild asthma or those who have not been diagnosed with asthma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized asthma treatments, reducing symptoms and healthcare costs for patients.
How similar studies have performed: Previous research has shown promise in using genetic approaches to tailor treatments for other conditions, suggesting potential success for this novel approach in asthma.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Tantisira, Kelan G — University of California, San Diego
- Study coordinator: Tantisira, Kelan G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.